🇺🇸 FDA
Pipeline program

FULVESTRANT, M1774 50mg, M1774 30mg

Phase 2 small_molecule active

Quick answer

FULVESTRANT, M1774 50mg, M1774 30mg for advanced breast cancer is a Phase 2 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Institut für biomedizinische Analytik NMR-Imaging GmbH
Indication
advanced breast cancer
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials